Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • When Smartphones Ran Out of Ideas, AI Showed Up Technology
  • Miles Education: Where India Learns to Think Like Global Financial Leaders Education
  • Global Experts Deliberate on Democracy in the Age of AI at DSVV Business
  • Star Studios and Cine1 Studios’ powerful edge of the seat survival thriller Apurva to have its World TV Premiere on Star Gold on 21st April at 12 pm Entertainment
  • 15 Songs One Story Krispy Rishtey Directed by Jagat Singh Now Streaming on Jio Cinema Entertainment
  • Dr. Vikas Singhal Honored with Bharat Shri Award 2025 for Advancing Evidence-Based Homeopathic Practice Health
  • RedTeam Summit 2023: Uniting Top Cybersecurity Experts for a Collective Exchange of Knowledge Business
  • Damjan Lukic, Restaurant owner made a perfect recipe for entrepreneurship Business

Vaishali Pharma received orders worth USD 73.85 million (Approx Rs. 600 crore) from overseas buyers

Posted on March 1, 2023 By

Mr. Atul Vasani, Managing Director, Vaishali Pharma

Mumbai (Maharashtra) [India], March 1: Mumbai based Vaishali Pharma Ltd has received orders worth USD 73.85 million (Approx. Rs. 600 crore) from overseas buyer for purchase of Antibiotics Pharmaceutical products. Company has completed the due diligence with the overseas partners and have discussed various prospects for the long-term relations and look forward to achieve more orders from them. This order will be executed within 6 to 8 months and subject to initial advance payment as per the agreed terms of the contract.

Vaishali Pharma Limited is one of the fastest-growing and versatile companies in the pharmaceutical industry. It has a strong presence in both the domestic and export markets and is currently a supplier to all leading Indian and multinational pharmaceutical companies. The company has been catering to semi-regulated and nonregulated markets across the globe. Company holds altogether 250+ Brands in Finished Formulations, Registered in International Market.

Commenting on the development, Mr. Atul Vasani, Managing Director, Vaishali Pharma Ltd said, “We are happy to share the news that, we have received the order worth 73.85 Million USD with an overseas buyer for purchase of Antibiotics Pharmaceutical products. This is the result of correspondence with them since last 6 months. This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months. As per our Company’s policy we have done the Due diligence and respective contracts with the overseas Company. We have discussed various prospects with the company for the long term relations and also we look forward to achieve more orders from them.”

Established in 1989, Vaishali Pharma Limited is a globally well trusted brand with high quality products, accepted by companies across the globe. The Company is amongst the leading players in the supply of pharma products – Bulk Drugs / APIs, Formulations, Surgical Products, Veterinary supplements, Herbal & Nutraceutical products, with a well-established brand known for its high-quality products & services amongst various clients globally. The company has over 250 + formulation brands marketed in multiple countries; of which dossier is in CTD format along with its respective bioequivalence. The company has built a robust pipeline of around 250 Dossiers. The Company’s synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent rapport with clients.

Company is engaged in supply of pharmaceutical products to corporates, hospitals and retails stores in all SKUs required. Company’s products have made its grasp on the overseas market and getting excellent feedback worldwide. The Company is showing consistent agility and innovation by meeting the needs of its customers in both Domestic and International markets.

Vaishali Pharma Limited, continue to remain steadfast in our transformation journey, building additional pathways of growth and simultaneously focusing on making the organisation more efficient, and believe that the “Quality is an ongoing process of building and sustaining relationship.” Our strong commitment of providing quality products is boosted by in-depth industry knowledge, well-qualified team of professionals, as well as hi-tech and advanced infrastructure, resultantly, creating mutually beneficial associations for all parties involved.

“Quality being the primary goal of our association, is the Strength of our Partnership. We have strong foothold in sourcing various products in India. Wherein Vaishali Pharma, is a 30 years old pharmaceutical organization, entirely involved in International Business Marketing of Pharmaceutical Products; along with Nutraceutical Products for Domestic and International Market. Our International associations are entirely backed by the Quality Norms we adhere for All Our Products. This will help Company to achieve milestone and reach to new heights,” said Mr. Vasani.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: Dissemination of Key messages of Achhi Aadat Campaign through Public Transport (Autorickshaws) in New Delhi
Next Post: Industry gearing up for Asia’s largest show on woodworking, furniture manufacturing & mattress manufacturing – DELHIWOOD 2023

Related Posts

  • Garment Technology Expo 2023: Uniting Over 550 Classy Brands in Delhi/NCR’s Fashion Hub Business
  • Steel Exchange India Limited Achieves Highest-Ever Re-Bar Production in September 2026 and for the Quarter Ended September 30, 2026 Business
  • Prime Landmarks owners Mangesh Warule and AvinashJagdale felicitated as Trendsetters 2022 by Maharashtra Times Business
  • VPRPL Strengthens Financial Position with Rs 285 Cr Promoter Infusion and Significant Debt Reduction Business
  • PhoneDekho.co.in poised to revolutionise smartphone re-commerce in India Business
  • Reliance Industries Rewards Investors with ₹5.50 Dividend for FY25, Unveils Bold ₹25,000 Cr Fundraising Plan Business

Recent Posts

  • PPFAS Asset Management appoints Devendra Ghalsashi as Chief Operating Officer
  • Irfan Pathan and Adah Sharma Grace the Launch of Youth Cricket League’s YCLT10
  • From Military Service to Social Change: Ramesh Sangle Explores Nation-Building in BRIGADE
  • Samiran Tea Unveils New Product Portfolio, Including 10 Herbal Tea Blends, at Noida Office Inauguration
  • Manav’s ‘Bardic Voices: Where the Horizon Meets, the Magic Begins’ Explores Memory, Humanity, and the Search for Meaning

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • India’s one of the largest solar module Manufacturer Rayzon Solar now to produce solar modules in USA Business
  • World’s Largest and First-Ever Siddha Mahamrityunjay Yantra Announced with Groundbreaking Ceremony in Hisar Lifestyle
  • Mr Y. R. Reddy expressed gratitude towards HH Shiekh Hamdan for the fitness motivation at Dubai Run Event Business
  • Agarwal Toughened Glass India Limited Q1 FY27 Business Update, Revenue grows ~23% QoQ to ₹ 34.40 Crores Business
  • Hubble Explorers Wins ‘Best Preschool Curriculum in India’ at the Early Years Educators Summit and Awards 2025 Business
  • Business Icons 2024: A Showcase of the Top 10 Companies Defining Success Business
  • Fredun Pharmaceuticals Announces 2:1 Bonus Issue, Signaling Strong Growth Confidence Business
  • Maharashtra Governor Ramesh Bais released the book Narendra Modi Sanvad Naye Bharat Ka Sankalp written by Dr. Mustafa Yusuf Ali Gom National

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme